Thor Investment Management’s Gilead Sciences GILD Stock Holding History

Thor Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300	Closed	-$36.8K	–	51
2025 Q4	$36.8K	Hold	300	–	–	0.02%	41
2025 Q3	$33.3K	Hold	300	–	–	0.02%	43
2025 Q2	$33.3K	Sell	300 -100	-25%	-$10.6K	0.02%	42
2025 Q1	$44.8K	Hold	400	–	–	0.03%	37
2024 Q4	$36.9K	Hold	400	–	–	0.03%	43
2024 Q3	$33.5K	Hold	400	–	–	0.02%	46
2024 Q2	$27.4K	Buy	+400	New	+$26.7K	0.02%	44

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Thor Investment Management's GILD Position: Q2 2026 in Review

Thor Investment Management reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $34.5K and leaving 22,956 shares worth $2.9M. The position accounts for 1.65% of the portfolio, ranked #18.

Thor Investment Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.39M in Q4 2025. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Thor Investment Management held 22,956 shares of Gilead Sciences worth $2.9M as of Q2 2026.
Thor Investment Management sold 262 Gilead Sciences shares in Q2 2026, an estimated $34.5K.
Gilead Sciences made up 1.65% of Thor Investment Management's portfolio in Q2 2026, its #18 holding.
Thor Investment Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Thor Investment Management's Gilead Sciences position peaked at $6.39M in Q4 2025.
1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Thor Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.